Active ingredientPamapimodCat. No. P-P010-001CAS 449811-01-2Family · Pharmaceutical analytical standards
Pamapimod
An investigational inhibitor of p38 MAP kinase, a protein that controls the production of inflammatory molecules: in the 2000s it was studied for rheumatoid arthritis and later for osteoarthritis, without reaching approval. This family brings together the active ingredient and labelled standards.
Did you know?During the pandemic years it was rediscovered in tandem with pioglitazone, a diabetes drug: in the laboratory the two together showed synergistic antiviral activity against SARS-CoV-2.
Go to the active ingredient →Active ingredientPamapimodCat. No. P-P010-001CAS 449811-01-2
Isotopically labelledPamapimod-d4Cat. No. P-P010-002CAS 1246814-57-2No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.